Edgewise Therapeutics, Inc.
EWTXNasdaqCIK 1710072HealthcareFiscal year ends Dec 31
Reports and events: 94 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0612:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-091670 |
| 2026-08-0612:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091671 |
| 2026-07-1612:01 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-26-084088 |
| 2026-07-1312:37 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-082902 |
| 2026-06-0520:33 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-071011 |
| 2026-06-0112:51 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-249951 |
| 2026-05-0713:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-056783 |
| 2026-05-0712:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-056713 |
| 2026-04-2720:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001388325-26-000014 |
| 2026-04-2320:06 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001104659-26-047688 |
| 2026-02-2613:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-020112 |
| 2026-02-2613:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-020108 |
| 2025-11-2022:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-114660 |
| 2025-11-1022:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-109295 |
| 2025-11-0613:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-107427 |
| 2025-11-0613:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107419 |
| 2025-08-0712:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-010655 |
| 2025-08-0712:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074987 |
| 2025-06-2620:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-063028 |
| 2025-05-1223:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-25-000490 |
| 2025-05-0812:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006857 |
| 2025-05-0812:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045896 |
| 2025-04-2920:15 ET | DEF 14A | Proxy statementPeriod 2025-06-13 | 0001558370-25-005845 |
| 2025-04-0210:29 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-030870 |
| 2025-04-0210:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-030839 |
| 2025-03-0313:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002006 |
| 2025-03-0313:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-019498 |
| 2025-01-2213:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-005075 |
| 2024-12-1622:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-129001 |
| 2024-11-1222:23 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000874 |
| 2024-11-0713:07 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014762 |
| 2024-11-0713:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115077 |
| 2024-09-2301:20 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-223906 |
| 2024-08-1221:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-088426 |
| 2024-08-0812:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011477 |
| 2024-08-0812:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087031 |
| 2024-06-1101:09 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-070114 |
| 2024-05-1013:10 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-059674 |
| 2024-05-0912:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001544784-24-000056 |
| 2024-05-0912:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059136 |
| 2024-05-0713:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-057783 |
| 2024-04-2620:10 ET | DEF 14A | Proxy statementPeriod 2024-06-07 | 0001558370-24-005905 |
| 2024-02-2213:07 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-001467 |
| 2024-02-2213:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-026336 |
| 2024-01-2521:26 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-015434 |
| 2024-01-2521:25 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000068 |
| 2024-01-1913:44 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-005031 |
| 2024-01-1911:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events | 0001104659-24-004966 |
| 2023-11-0913:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018427 |
| 2023-11-0913:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001700 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.